Latest Period
Q4 2025
Security Snapshot
Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) Institutional Ownership
CUSIP: 09075A108
13F Institutional Holders and Ownership History from Q1 2021 to Q1 2026
Institutions Reporting
147
Shares (Excl. Options)
50,188,737
Price
$7.44
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Class A Common Stock, $0.001 par value per share
- Symbol
- BVS on Nasdaq
- Shares outstanding
- 66,970,133
- Price per share
- $9.13
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 50,188,737
- Total reported value
- $373,359,713
- % of total 13F portfolios
- 0%
- Share change
- +1,521,915
- Value change
- +$11,519,442
- Number of holders
- 147
- Price from insider filings
- $9.13
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- BVS - Bioventus Inc. - Class A Common Stock, $0.001 par value per share is tracked under CUSIP 09075A108.
- 147 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 147 to 55 between Q4 2025 and Q1 2026.
- Reported value moved from $373,359,713 to $176,399,159.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 147 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 09075A108?
CUSIP 09075A108 identifies BVS - Bioventus Inc. - Class A Common Stock, $0.001 par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09075A108:
Significant Owners of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 9% | +13% | $46,565,003 | +$5,902,520 | 6,047,403 | +15% | Nantahala Capital Management, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 147 institutional investors reported holding 50,188,737 shares of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS). This represents 75% of the company’s total 66,970,133 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) together control 65% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 19% | 13,021,324 | 0% | 30% | $96,878,651 |
| Juniper Investment Company, LLC | 10% | 6,939,357 | 0% | 18% | $51,628,816 |
| Nantahala Capital Management, LLC | 9% | 6,047,403 | +4.1% | 2.7% | $44,992,678 |
| BlackRock, Inc. | 4.7% | 3,124,184 | +1.8% | 0% | $23,243,930 |
| VANGUARD GROUP INC | 4.5% | 2,984,927 | +2.1% | 0% | $22,207,857 |
| ROYCE & ASSOCIATES LP | 1.9% | 1,251,282 | -0.93% | 0.09% | $9,309,538 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 1,120,238 | +1.8% | 0% | $8,337,051 |
| STATE STREET CORP | 1.3% | 891,024 | +1.7% | 0% | $6,629,219 |
| AMERICAN CENTURY COMPANIES INC | 1.3% | 847,791 | -22% | 0% | $6,307,565 |
| DIMENSIONAL FUND ADVISORS LP | 1.1% | 765,208 | +2.9% | 0% | $5,693,196 |
| OBERWEIS ASSET MANAGEMENT INC/ | 0.92% | 616,614 | +2.5% | 0.17% | $4,587,608 |
| RENAISSANCE TECHNOLOGIES LLC | 0.92% | 615,100 | -24% | 0.01% | $4,576,344 |
| Eversept Partners, LP | 0.7% | 471,257 | +8.6% | 0.2% | $3,506,152 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.69% | 462,559 | +0.21% | 0.07% | $3,441,439 |
| Qube Research & Technologies Ltd | 0.67% | 449,006 | -14% | 0% | $3,340,605 |
| AQR CAPITAL MANAGEMENT LLC | 0.67% | 446,757 | +14% | 0% | $3,323,872 |
| Buckley Capital Advisors, LLC | 0.6% | 404,669 | 0% | 2.6% | $3,010,737 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.58% | 387,886 | 0.44% | $2,885,872 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.56% | 375,173 | -16% | 0% | $2,791,287 |
| GOLDMAN SACHS GROUP INC | 0.55% | 369,818 | -5.8% | 0% | $2,751,445 |
| FMR LLC | 0.55% | 366,686 | +25% | 0% | $2,728,141 |
| D. E. Shaw & Co., Inc. | 0.53% | 358,257 | +90% | 0% | $2,665,432 |
| NORTHERN TRUST CORP | 0.52% | 351,023 | -7% | 0% | $2,611,611 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.49% | 330,000 | +8.2% | 0.04% | $2,455,200 |
| BNP PARIBAS FINANCIAL MARKETS | 0.49% | 325,864 | 0% | 0% | $2,424,428 |
Institutional Holders of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 19,321,079 | $176,399,159 | +$10,764,084 | $9.13 | 55 |
| 2025 Q4 | 50,188,737 | $373,359,713 | +$11,519,442 | $7.44 | 147 |
| 2025 Q3 | 49,169,136 | $328,942,973 | +$4,728,185 | $6.69 | 133 |
| 2025 Q2 | 48,385,322 | $320,311,775 | +$5,188,602 | $6.62 | 132 |
| 2025 Q1 | 46,840,874 | $428,590,821 | +$16,740,551 | $9.15 | 143 |
| 2024 Q4 | 45,507,445 | $477,832,216 | +$658,698 | $10.50 | 149 |
| 2024 Q3 | 44,941,761 | $537,109,536 | +$77,623,131 | $11.95 | 137 |
| 2024 Q2 | 38,578,679 | $221,831,767 | +$26,597,543 | $5.75 | 100 |
| 2024 Q1 | 34,228,194 | $177,979,045 | +$4,782,770 | $5.20 | 84 |
| 2023 Q4 | 33,292,235 | $175,449,385 | +$2,510,502 | $5.27 | 80 |
| 2023 Q3 | 32,998,084 | $108,893,302 | +$3,595,601 | $3.30 | 67 |
| 2023 Q2 | 31,892,411 | $92,170,679 | +$3,183,214 | $2.89 | 65 |
| 2023 Q1 | 31,258,956 | $33,581,111 | -$4,749,675 | $1.07 | 71 |
| 2022 Q4 | 31,381,765 | $81,902,823 | -$22,341,854 | $2.61 | 84 |
| 2022 Q3 | 35,052,070 | $245,361,886 | +$7,458,042 | $7.00 | 93 |
| 2022 Q2 | 33,976,343 | $231,717,964 | +$12,640,844 | $6.82 | 93 |
| 2022 Q1 | 31,706,911 | $446,993,897 | +$7,048,976 | $14.10 | 100 |
| 2021 Q4 | 31,175,535 | $451,621,332 | +$89,759,637 | $14.49 | 94 |
| 2021 Q3 | 24,847,152 | $351,827,300 | +$55,491,790 | $14.16 | 66 |
| 2021 Q2 | 20,703,857 | $364,387,973 | -$15,203,525 | $17.60 | 51 |
| 2021 Q1 | 21,873,216 | $334,224,000 | +$334,224,000 | $15.28 | 45 |